Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Filippo Dell’aNno has a total of 158 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Equine Sarcoid: From BPV-Driven Oncogenesis to Host-Sustained Tumor Persistence

    by Filippo Dell’Anno, Chiara Trebino, Floriana Fruscione, Chiara Grazia De Ciucis, Livia De Paolis, Katia Cappelli, Elisabetta Razzuoli

    Equine sarcoid is the most common cutaneous neoplasm of equids and represents a distinctive model of virus-associated tumor persistence. Although bovine papillomaviruses, particularly BPV-1 and BPV-2, are recognized as the main etiological agents, viral infection alone does not fully explain the clinical heterogeneity, frequent recurrence, and limited spontaneous regression of these lesions. This review summarizes current evidence on the molecular and cellular mechanisms underlying equine sarcoid pathogenesis, with emphasis on the interaction between BPV infection, host signaling pathways, tumor microenvironment dynamics, and multi-omic evidence of host regulatory networks. BPV oncoproteins, especially E5, promote fibroblast transformation through PDGFβR activation, downstream PI3K/AKT, MAPK and p38 signaling, altered cell survival, and immune evasion mediated by impaired antigen presentation. However, sarcoid persistence appears to depend on broader host-driven processes, including extracellular matrix remodeling, activated fibroblastic and myofibroblastic phenotypes, chronic inflammatory signaling, and ineffective immune clearance. Recent transcriptomic and epigenomic studies further indicate that long non-coding RNAs, DNA methylation changes, circulating microRNAs, and recently identified virus–host chimeric transcripts may contribute to stabilization of the neoplastic phenotype and may represent future biomarkers. Overall, this review proposes a virus-initiated, host-sustained conceptual framework for equine sarcoid pathogenesis, in which viral oncogene activity and host tissue reprogramming cooperate to promote lesion persistence, recurrence, and therapeutic resistance.

  • Open Access

    Relative HPV Viral Load Measured by ΔCt for Risk Stratification in Cervical Cancer Screening

    by Morena D’Avenia, Laila Sara Arroyo Mühr, Marcella Mastromauro, Federica Spadaccino, Elisabetta Razzuoli, Michela Iacobellis, Filippo Dell’Anno

    Background/Objectives: Human papillomavirus (HPV) testing is widely used in cervical cancer screening because of its high sensitivity, although its limited specificity requires effective triage strategies. This study aimed to evaluate the association between relative viral load (RVL) and cervical lesion severity, focusing on HPV-positive women with non-high-grade cytology. Methods: The study included 997 women with histological outcomes from a cohort of 2765 HPV-positive individuals identified among 37,030 women screened in the Bari metropolitan area (Italy) using a real-time HPV-DNA test. Associations between RVL, estimated using the ΔCt method, and lesion severity were assessed using histological and cytological classifications. Logistic regression models evaluated the independent effect of RVL, adjusting for age and HPV detection channel. Results: Lower ΔCt values (indicating higher RVL) were significantly associated with high-grade lesions (CIN2+) (OR = 0.91, 95% CI: 0.89–0.94, p < 0.001). The association was observed for HPV16 and the pooled 12-high-risk HPV detection channel, while no significant association was observed for HPV18. A similar association was observed when cytological classification was used as the outcome. Age showed a modest effect, with reduced odds of high-grade lesions observed in women aged ≥50 years. Among women with non-high-grade cytology who subsequently underwent histological assessment, 17.6% had underlying CIN2+, and RVL remained significantly associated with lesion severity in this subgroup. However, ΔCt showed only modest discrimination for high-grade lesions [AUC = 0.643 (95% CI: 0.605–0.681)]. Conclusions: Higher HPV RVL is associated with increased lesion severity, particularly for HPV16 and the pooled 12-high-risk detection channel, but not for HPV18. Given its modest standalone discriminatory performance and the selected nature of the histologically verified cohort, ΔCt should be considered an exploratory marker rather than a validated triage tool. Prospective validation is required to determine whether it provides incremental clinical value.

  • Open Access

    Integrated transcriptomic profiling reveals oncogenic pathways and chimeric transcripts in equine sarcoid lesions with predominant BPV1 detection

    by Samanta Mecocci, Stefano Capomaccio, Ilaria Porcellato, Filippo Dell’ANno, Roberta Ratto, Luca Mechelli, Livia De Paolis, Floriana Fruscione, Benedetta Passeri, Rodolfo Gialletti, et al.

    Sarcoids are the most common cutaneous tumors in horses, representing up to 90% (35%–90%) of skin neoplasms. Mostly caused by Bovine Papillomavirus (BPVs) infections, sarcoids are highly resistant to therapy and prone to recurring, posing a significant threat to equine health. The aim of this study is to explore molecular pathogenetic mechanisms underlying the development of equine sarcoids, by applying transcriptomic approach. After testing samples for viral DNA, both mRNA and small RNA expression was analyzed via high-throughput Illumina sequencing comparing 12 sarcoids and 12 healthy skin samples as controls. Differentially expressed genes (DEGs), DE miRNAs (sarcoids vs. controls) and miRNA-DEG couples with opposite expression trends, were retrieved and subjected to a functional analysis. Over 6K DEGs emerged, 3620 down-regulated and 2415 up-regulated along with 145 DE miRNAs, 56 downregulated and 89 upregulated. Among the enriched biological processes for DEGs, some were related to growth factors production and collagen binding, cell migration and proliferation, tissue morphogenesis and inflammatory response. Interestingly, “Pathways in cancer” and “Hippo signaling pathway” were enriched KEGG pathways for the miRNA-DEG couples. Our data identified a great transcription discrepancy between sarcoid lesions and healthy skin with an overall enrichment for processes related to cellular transformation. RNA-seq sequencing depth allowed the search for candidate chimeric transcripts associated with viral integration events. Chimeric RNAs can influence gene regulation and may contribute to tumor growth and immune modulation. Via computational analysis we identified six fusion loci in tumor samples and in two sarcoid margins, with the most frequent event involving WNT10B and FKBP11. This fusion, detected in 6/10 sarcoids, is of particular interest since WNT10B activates the WNT/β-catenin cascade, while FKBP11 has been implicated in osteosarcoma progression. Although functional validation is ongoing, this represents the first report of chimeric transcripts in equine sarcoids, opening new perspectives on BPV-driven oncogenesis.


  • Open Access

    Targeting Toll-like Receptor 2: synthetic diacylated lipopeptides polarize equine macrophages towards a pro-inflammatory phenotype

    by De Ciucis, Chiara Grazia, Floriana Fruscione, Filippo Dell’Anno, Susanna Zinellu, Emanuela Giaconi, Simone Loi, Nicolò Columbano, Giulia Franzoni, Elisabetta Razzuoli

    Toll-like receptors (TLRs) are a group of pattern recognition receptors (PRRs), that play critical roles in initiating host immune defenses. TLR-2 agonists can activate innate immune cells and thus are attracting increasing attention as prophylactic and/or therapeutic agents against infectious diseases or in cancer immunotherapy. In this work, the impact of three synthetic diacylated lipopeptides (Mag-Pam2Cys_P48, MagPam2Cys_P80, and Mag-Pam2Cys_MAG1000) on equine monocyte-derived macrophages (moMΦ) phenotype and functionality was thoroughly investigated. MoMΦ were generated in vitro from circulating monocytes, and they were stimulated with these TLR-2 agonists, alongside untreated controls. The immunomodulatory effect was evaluated by RT-qPCR (expression of key immune genes) and ELISA multiplex (release of cytokines). Subsequently, the impact of MagPam2Cys_P80 on the phenotype of cells stimulated with IL-4 or IL-10 (‘M2-related’ cytokines) was investigated. We observed that stimulation with the three synthetic diacylated lipopeptides polarizes moMΦ towards a pro-inflammatory phenotype, with enhanced induction/release of pro-inflammatory cytokines, but with lower intensity compared to classical activation (IFN-γ + LPS). No differences between these agonists were detected, thus one of them (Mag-Pam2Cys_P80) was selected for further experiments with moM(IL-4) or moM(IL-10). Our data revealed that MagPam2Cys_P80 triggered increased release of IL-8, but not IL-1β, from moM(IL-10) 24 h after stimulation. In addition, TNF release was not observed when cells were simultaneously stimulated with IL-10. These data suggest that the inflammatory activity evoked by those agonist compounds could be partially mitigated in vivo by the release of anti-inflammatory molecules (e.g. IL-10), avoiding a potentially harmful dysregulated inflammatory response.

  • Open Access

    Epidemiology of Splenic Lesions in Dogs Undergoing Splenectomy—Pathological Characterization and Risk Factors

    by Filippo Dell’anno, Lucia Minelli, Giuseppe Giglia, Elvio Lepri, Marta Mechelli, Livia De Paolis, Floriana Fruscione, Elisabetta Razzuoli, Elisabetta Manuali

    Splenic lesions are common in dogs and can have important clinical implications due to the risk of rupture causing life-threatening hemorrhage, or, for neoplastic lesions, potential metastatic spread. This retrospective study analyzed 682 canine spleen samples submitted to the Regional Canine Cancer Registry in Umbria, Italy, between 2014 and 2023, aiming to characterize lesion types and explore associations with demographic factors and clinical outcomes. Lesions were classified as neoplastic or non-neoplastic. Non-neoplastic lesions were predominant (54.3%), mainly nodular hyperplasia, hematoma, and congestion, while neoplastic lesions accounted for 45.7%, with hemangiosarcoma (HSA) being the most frequent neoplasm (54.5%), followed by other sarcomas, lymphomas, and rare tumors. The mean age at diagnosis was 10.4 years, and medium-sized dogs living in urban areas were most affected. No significant differences in lesion type were observed between sexes or between purebred and mixed-breed dogs, although purebreds were more represented overall. HSA risk varied by size, sex, and breed, with large dogs and certain pure breeds showing elevated risk. Survival analysis revealed markedly reduced outcomes for dogs with HSA. These findings emphasize the utility of histopathologic diagnosis in guiding clinical management and provide insight into the epidemiology and prognosis of splenic lesions in dogs.


  • Investigation of tumor immune microenvironment (TIME) in feline nasal planum cutaneous squamous cell carcinomas (CSCC)

    by L. De Paolis, F. Armando, F. Dell'ANno, M. Di Pentima, I. Porcellato, C. Brachelente, B. Passeri, K. Cappelli, L. Mechelli, S. Mecocci, et al.

  • Open Access

    Cadmium and cancer: A study on canine tumours and environmental bioindicators (Sus scrofa)

    by Filippo Dell’ANno, Roberta Giugliano, Livia De Paolis, Ines Crescio, Elisabetta Razzuoli


  • Open Access

    Quality Assurance in Cervical Cancer Screening: Evaluation of Sample Adequacy in HPV DNA Testing

    by M. D'AVenia, F. Dell'ANno, M. Martinelli, L. Santomauro, R. C. Njoku, L.S. Arroyo Mühr, M. Iacobellis, C. E. Cocuzza

    In HPV‐primary screening, sample quality significantly influences test accuracy. Unlike cytology‐based screening, no consensus guidelines presently exist for sample quality assessment in HPV testing. This study aims to evaluate the impact of sample cellularity on HPV testing. A total of 37 592 liquid‐based cytology (LBC) samples from women undergoing HPV‐primary screening (aged 30–64, median 48; IQR: 40–56 years) were analyzed using Cobas 4800 HPV Test (Roche). Sample adequacy was assessed by the assay's β‐globin internal control and by an independent quantitative cellularity assessment (OncoPredict HPV, Hiantis). HPV positivity rates (PR) were stratified according to β‐globin Ct values. Among the analyzed samples, 50.0%, 47.1%, 2.3%, and 0.6% had β‐globin Ct values of ≤ 28, > 28 to ≤ 32, > 32 to ≤ 34, and > 34, respectively. Overall HPV‐PR was 7.7% (2891/37 592). PR reached 9.7% in samples with β‐globin ≤ 28 Ct (1820/18 801), decreasing markedly to 1.4% for β‐globin > 34 Ct (3/214), ( p < 0.001). Quantitative analysis showed that Cobas 4800 β‐globin Ct = 34 corresponds to approximately 1.5 × 10^3 nucleated cells/reaction. A subset of 195 HPV‐negative samples with β‐globin Ct ≥ 34 was evaluated by liquid based cytology (LBC): 19% had inadequate cellularity according to LBC guidelines, 8% were ≥ ASC‐US and 73% NILMs. 65% of adequate LBC showed cellular atrophy. These findings emphasize the importance of assessing cellularity in HPV‐screening to avoid potentially false‐negative results due to inadequate samples. Future research should focus on establishing standardized cellularity thresholds to improve screening accuracy.


  • Open Access

    Evaluation of attenuated Salmonella Typhimurium (STMΔznuABC) anticancer activity on canine mammary cancer-associated fibroblasts

    by Barbara Chirullo, Floriana Fruscione, Genny Del Zotto, Filippo Dell'ANno, Michela Tarantino, Ilaria Porcellato, Paola Petrucci, Chiara Grazia De Ciucis, Antonello Bufalari, Lisa Guardone, et al.


  • Open Access

    Expression of key immune genes in polarized porcine monocyte-derived macrophage subsets

    by Giulia Franzoni, Floriana Fruscione, Filippo Dell’ANno, Lorena Mura, Chiara G. De Ciucis, Susanna Zinellu, Nicolò Columbano, Simon P. Graham, Silvia Dei Giudici, Elisabetta Razzuoli